Sosei Heptares has significantly grown. Driving that growth has been an increasing number of clinical studies. Alex Godwood, Director of Statistics for the international biopharmaceutical group, recognised that a better way forward for data analysis requirements was needed to enable the next phase of growth.
An off-the-shelf solution did not provide the level of control around the data that was needed. What was required was a solution tailored to the business needs. Providing flexibility within the platform to maximise any future opportunities. It was key to build something that could be adapted as they grew.
Katalyze Data worked alongside Sosei to create a fully customised validated structure. Meaning that they have full control over all the processes and the data that they process. The system saves the company time and improves efficiencies within the business because everything is linked and easily accessible.